Advanced search
Publication Cover
Expert Review of Anticancer Therapy Volume 11, 2011 - Issue 8
Submit an article Journal homepage
1,346
Views
30
CrossRef citations to date
0
Altmetric
Editorial

Targeting the leptin receptor: a potential new mode of treatment for breast cancer

Laszlo Otvos Temple University, Biological Life Sciences Building, 1900 North 12th Street, Philadelphia, PA 19122, USA and Peptherx Inc., Philadelphia, PA, USA. [email protected]
&
Eva Surmacz Temple University, Biological Life Sciences Building, 1900 North 12th Street, Philadelphia, PA 19122, USA and Peptherx Inc., Philadelphia, PA, USA
Pages 1147-1150 | Published online: 10 Jan 2014

References

  • Jemal A, Bray F, Center MM et al. Global cancer statistics. CA Cancer J. Clin.61, 69–90 (2011).
  • American Cancer Society. Cancer Facts & Figures 2010. American Cancer Society, Atlanta, GA, USA (2010).
  • Orlando L, Schiavone P, Fedele P et al. Molecularly targeted endocrine therapies for breast cancer. Cancer Treat. Rev.36, S67–S71 (2010).
  • Perou CM, Sorlie T, Eisen MB et al. Molecular portraits of human breast tumors. Nature406, 747–752 (2000).
  • Ismail-Khan R, Bui MM. A review of triple-negative breast cancer. Cancer Control17, 173–176 (2008).
  • Chacon RD, Costanzo MV. Triple-negative breast cancer. Breast Cancer Res.12(S2), S3 (2010).
  • De Ruijter TC, Weeck J, de Hoon JPJ et al. Characteristics of triple-negative breast cancer. J. Cancer Res. Clin. Oncol.137, 183–192 (2011).
  • Vona-Davis L, Rose DP. The influence of socioeconomic disparities on breast cancer tumor biology and prognosis: a review. J. Womens Health18, 883–893 (2009).
  • Anders CK, Carey LA. Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer. Clin. Breast Cancer9, S73–S81 (2009).
  • Davies E, Hiscox S. New therapeutic approaches in breast cancer. Maturitas68, 121–128 (2011).
  • Cleary MP, Grossmann ME, Ray A. Effect of obesity on breast cancer development. Vet. Pathol.47, 202–213 (2010).
  • Porter GA, Inglis KM, Wood LA et al. Effect of obesity on presentation of breast cancer. Ann. Surg. Oncol.13, 327–332 (2006).
  • Surmacz E. Obesity hormone leptin: a new target in breast cancer? Breast Cancer Res.9, 301 (2007).
  • Otvos L Jr, Kovalszky I, Riolfi M et al. Efficacy of a leptin receptor antagonist peptide in a mouse model of triple-negative breast cancer. Eur. J. Cancer47, 1578–1584 (2011).
  • McMurtry V, Simeone AM, Nieves-Alicea R et al. Leptin utilizes Jun N-terminal kinases to stimulate the invasion of MCF-7 breast cancer cells. Clin. Exp. Metastasis26, 197–204 (2009).
  • Vona-Davis L, Rose DP. Angiogenesis, adipokines and breast cancer. Cytokine Growth Factor Rev.20, 193–201 (2009).
  • Fusco R, Galgani M, Procaccini C et al. Cellular and molecular crosstalk between leptin receptor and estrogen receptor-α in breast cancer: molecular basis for a novel therapeutic setting. Endocr. Relat. Cancer17, 373–382 (2010).
  • Fiorio E, Mercanti A, Terrasi M et al. Leptin/HER2 crosstalk in breast cancer: in vitro study and preliminary in vivo analysis. BMC Cancer8, 305 (2008).
  • Ray A, Cleary MP. Leptin as a potential therapeutic target for breast cancer prevention and treatment. Expert Opin. Ther. Targets14, 443–51 (2010).
  • Peelman F, Van Beneden L, Zabeau H et al. Mapping of the leptin binding sites and design of a leptin antagonist. J. Biol. Chem.279, 41038–41046 (2004).
  • Elinav E, Niv-Spector L, Katz M et al. Pegylated leptin antagonist is a potent orexigenic agent: preparation and mechanism of activity. Endocrinology150, 3083–3091 (2009).
  • Shpilman M, Niv-Spector L, Katz M et al. Development and characterization of high affinity leptins and leptin antagonists. J. Biol. Chem.286, 4429–4442 (2011).
  • Gonzalez R, Watters A, Xu Y et al. Leptin-signaling inhibition results in efficient anti-tumor activity in estrogen receptor positive or negative breast cancer. Breast Cancer Res.11, R36 (2009).
  • Otvos L Jr, Terrasi M, Cascio S et al. Development of a pharmacologically improved peptide agonist of the leptin receptor. Biochim. Biophys. Acta1783, 1745–1754 (2008).
  • Otvos L Jr, Kovalszky I, Scolaro L et al. Peptide-based receptor antagonists for cancer treatment and appetite regulation. Biopolymers96, 117–125 (2011).
  • Ferla R, Bonomi M, Otvos L Jr et al. Glioblastoma-derived leptin induces tube formation and growth of endothelial cells: comparison with VEGF effects. BMC Cancer (2011) (In Press).
  • Otvos L Jr, Shao W-H, Vanniasinghe A et al. Toward understanding the role of leptin and leptin receptor antagonism in preclinical models of rheumatoid arthritis. Peptides DOI: 10.1016/j.peptides.2011.06.015 (2011) (Epub ahead of print).
  • Hanson LR, Frey WH 2nd. Strategies for intranasal delivery of therapeutics for the prevention and treatment of neuroAIDS. J. Neuroimmune Pharmacol.2, 81–86 (2007).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.